Materials • Major Chemicals
$3.09 ▲ +0.10
(+3.34%)
MKT CAP: $5.6M • VOL: 3.0K
52W L $2 52W H $12
GURE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $25.4M | $7.7M | $30.0M |
| YoY Revenue Growth % | +231.8% | -74.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.6M | -$22.2M | -$11.9M |
| Operating Margin % | -33.7% | -80.0% | -39.6% |
| Net Income (GAAP) | -$43.9M | -$59.9M | -$61.8M |
| EBITDA (Normalized) | -$1.5M | $890.3K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.8M | $675.8K | -$32.8M |
| Capital Expenditures (CapEx) | $8.8M | $28.9M | — |
| Free Cash Flow (FCF) | -$1.0M | -$28.2M | -$32.8M |
| FCF Margin % | -4.1% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -6.1% | -12.3% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $111.5M | $142.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GURE.